Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma

BACKGROUND: Identifying factors conferring responses to therapy in cancer is critical to select the best treatment for patients. For immune checkpoint inhibition (ICI) therapy, mounting evidence suggests that the gut microbiome can determine patient treatment outcomes. However, the extent to which g...

Descripción completa

Detalles Bibliográficos
Autores principales: Limeta, Angelo, Ji, Boyang, Levin, Max, Gatto, Francesco, Nielsen, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2020
Materias:
Clinical Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714408/
https://www.ncbi.nlm.nih.gov/pubmed/33268597
http://dx.doi.org/10.1172/jci.insight.140940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714408/
https://www.ncbi.nlm.nih.gov/pubmed/33268597
http://dx.doi.org/10.1172/jci.insight.140940

Ejemplares similares